Enzo Biochem, Inc. (ENZ)

Provides diagnostic products and research tools for clinical laboratories and researchers, specializing in genetic analysis and molecular diagnostics.

ENZ Stock Quote

Company Report

Enzo Biochem, Inc. is a versatile company specializing in diagnostics, clinical laboratory services, and life sciences. Founded in 1976 and headquartered in Farmingdale, New York, Enzo Biochem operates through three key segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics.

The Life Sciences Products segment is dedicated to developing, manufacturing, and marketing a wide range of products and tools essential to clinical research, drug development, and bioscience research. These include proteins, antibodies, peptides, small molecules, labeling probes, and kits used for target identification/validation, gene expression analysis, nucleic acid detection, and cellular analysis. Their products cater to researchers focusing on cancer, cardiovascular disease, neurological disorders, diabetes, infectious diseases, and more.

Enzo Biochem's Clinical Laboratory Services segment operates a comprehensive clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. They offer molecular and other clinical tests crucial for patient care, aiding physicians in diagnosis, treatment monitoring, and identifying undiagnosed conditions. Additionally, the company operates rapid response laboratories in New York City and Connecticut, alongside a full-service phlebotomy center and in-house logistics department.

The Therapeutics segment focuses on innovative approaches in gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its products and services globally through a direct sales force and a network of distributors, ensuring widespread availability and support for its advanced biomedical solutions.

ENZ EPS Chart

ENZ Revenue Chart

Stock Research

FR WTTR IBIO AFG EGO AGAE HNRG

ENZ Chart

View interactive chart for ENZ

ENZ Profile

ENZ News

Analyst Ratings